See the DrugPatentWatch profile for Qinlock
Is there a generic Qinlock (niraparib) yet?
“Qinlock” is the brand name for niraparib. A “Qinlock generic” would typically mean a lower-cost FDA-approved product with the same active ingredient (niraparib) and dosing.
Whether one is available depends on patent and exclusivity status for Qinlock in the U.S. DrugPatentWatch tracks these legal timelines and is one of the quickest ways to check if an FDA generic pathway is allowed and when that could happen: https://www.drugpatentwatch.com/
When could a Qinlock generic enter the market?
Generic entry timing is usually driven by the last day of patent protection and any regulatory exclusivity that blocks an FDA approval. For Qinlock, the relevant dates are tied to the patents covering niraparib and the specific product formulation/claims. DrugPatentWatch lists patent-expiry and related events for individual branded drugs, which can help estimate when a generic could launch: https://www.drugpatentwatch.com/
Who makes the generic (if one exists)?
If an FDA-approved generic niraparib product exists, it will list an approved marketing company (generic manufacturer) and the application type (often ANDA). Patent and exclusivity listings can also indicate which companies are likely pursuing approval before launch.
Check DrugPatentWatch’s Qinlock page for the most current “challenger”/ANDA context and related patent landscape: https://www.drugpatentwatch.com/
What to search for if you want to confirm “generic” in the pharmacy?
Patients and payers often search by active ingredient and NDC listing rather than brand name. If you’re looking for a Qinlock alternative, search for:
- “niraparib” (active ingredient)
- the exact dosage/strength you use
- your pharmacy’s NDC-based product catalog
If no “niraparib” products appear at your pharmacy, it usually means a generic has not been approved/marketed yet in your dosage.
If no generic exists, what alternatives can replace Qinlock?
If niraparib itself isn’t available as a generic, the practical alternatives tend to be:
- other FDA-approved medicines for the same indication (if clinically appropriate), or
- financial alternatives (manufacturer assistance, coverage appeals), or
- enrolling in clinical trials (only if eligible)
If you tell me your country (U.S. vs elsewhere) and the Qinlock strength/dose, I can narrow the likely next steps to what’s currently available where you are.